These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12714609)

  • 21. Significance of mucin on the ocular surface.
    Watanabe H
    Cornea; 2002 Mar; 21(2 Suppl 1):S17-22. PubMed ID: 11995804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid-based thin-prep cytology study of lacrimal drainage system in primary acquired nasolacrimal duct obstruction.
    Jang JK; Choi SE; Lew H
    Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):3053-3059. PubMed ID: 35471740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC19 expression in human ocular surface and lacrimal gland and its alteration in Sjögren syndrome patients.
    Yu DF; Chen Y; Han JM; Zhang H; Chen XP; Zou WJ; Liang LY; Xu CC; Liu ZG
    Exp Eye Res; 2008 Feb; 86(2):403-11. PubMed ID: 18184611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of Tear Cytokine Expressions in Primary Acquired Nasolacrimal Duct Obstruction - Potential Insights into the Etiopathogenesis.
    Ali MJ; Patnaik S; Kelkar N; Ali MH; Kaur I
    Curr Eye Res; 2020 Apr; 45(4):435-439. PubMed ID: 31490706
    [No Abstract]   [Full Text] [Related]  

  • 25. Functional anatomy of human lacrimal duct epithelium.
    Paulsen F; Thale A; Kohla G; Schauer R; Rochels R; Parwaresch R; Tillmann B
    Anat Embryol (Berl); 1998 Jul; 198(1):1-12. PubMed ID: 9683063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Videoreflective dacryomeniscometry in normal adults and in patients with functional or primary acquired nasolacrimal duct obstruction.
    Francis IC; Chan DG; Papalkar D; Papas EB; Stapleton F
    Am J Ophthalmol; 2005 Mar; 139(3):493-7. PubMed ID: 15767059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. scRNA-Seq: First Atlas and Cellular Landscape of Lacrimal Sac: Implications in Primary Acquired Nasolacrimal Duct Obstruction Pathogenesis.
    Zhang W; Huang H; Liu X; Zhang L; Li L; Ding Y; Xiao Y; Ali MJ; Sun H; Xiao C
    Invest Ophthalmol Vis Sci; 2024 Mar; 65(3):38. PubMed ID: 38551583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lacrimal gland-associated mucins. Age related production and their role in the pathophysiology of dry eye].
    Schäfer G; Hoffmann W; Berry M; Paulsen F
    Ophthalmologe; 2005 Feb; 102(2):175-83. PubMed ID: 15678360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tear-Film Osmolarity Changes Following Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.
    Yuksel N; Akcay E; Ayan B; Duru N
    Curr Eye Res; 2017 Mar; 42(3):348-350. PubMed ID: 27419611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrolytes and electrophoretic studies of tear proteins in tears of patients with nasolacrimal duct obstruction.
    Lew H; Yun YS; Lee SY
    Ophthalmologica; 2005; 219(3):142-6. PubMed ID: 15947499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines.
    Gipson IK; Spurr-Michaud S; Argüeso P; Tisdale A; Ng TF; Russo CL
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2496-506. PubMed ID: 12766048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GP2-expressing cells in the conjunctiva and tear ducts of mice: identification of a novel type of cells in the squamous stratified epithelium.
    Kimura S; Kishimoto A; Mutoh M; Takahashi-Iwanaga H; Iwanaga T
    Biomed Res; 2015; 36(4):263-72. PubMed ID: 26299485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into the pathophysiology of primary acquired dacryostenosis.
    Paulsen FP; Thale AB; Maune S; Tillmann BN
    Ophthalmology; 2001 Dec; 108(12):2329-36. PubMed ID: 11733281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.
    Lee-Wing MW; Ashenhurst ME
    Ophthalmology; 2001 Nov; 108(11):2038-40. PubMed ID: 11713075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
    Ali MJ
    Prog Retin Eye Res; 2023 Sep; 96():101193. PubMed ID: 37394093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transcanalicular endoscopy of the lacrimal pathways].
    Shkol'nik SF; Shkol'nik GS
    Vestn Oftalmol; 2019; 135(4):78-82. PubMed ID: 31573560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach.
    Vernygorodskyi S
    Exp Oncol; 2013 Jun; 35(2):114-7. PubMed ID: 23828387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profile of aquaporins in human nasolacrimal duct epithelium.
    Jäger K; Reh D; Gebhardt M; Schaudig U; Sel S; Bräuer L; Paulsen F
    Curr Eye Res; 2010 Apr; 35(4):267-73. PubMed ID: 20373892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative Hormonal Profiling of the Lacrimal Drainage System: Potential Insights into the Etiopathogenesis of Primary Acquired Nasolacrimal Duct Obstruction.
    Ali MJ; Schicht M; Paulsen F
    Ophthalmic Plast Reconstr Surg; 2017; 33(5):381-388. PubMed ID: 28759505
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.